YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
91 hedge funds and large institutions have $330M invested in Y-mAbs Therapeutics in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 88 → 91 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.25% less ownership
Funds ownership: 57.89% → 56.64% (-1.2%)
Holders
91
Holding in Top 10
2
Calls
$2.59M
Puts
$6K
Top Buyers
| 1 | +$6.3M | |
| 2 | +$3.21M | |
| 3 | +$2.05M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.52M |
| 5 |
Millennium Management
New York
|
+$1.24M |
Top Sellers
| 1 | -$8.56M | |
| 2 | -$4.99M | |
| 3 | -$3.55M | |
| 4 |
Morgan Stanley
New York
|
-$2.53M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$2.32M |